| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Borgeson Blake is a Director at RECURSION PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $21.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 30, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 8,885 | $8.79 | $78,133.80 | -0.1% | -2.4% | -2.7% | |
| May 16, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 8,885 | $5.09 | $45,240.64 | -0.1% | +81.7% | +95.1% | |
| Apr 18, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 8,885 | $5.93 | $52,729.81 | -0.1% | +125.7% | +25.8% | |
| Apr 4, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 8,885 | $6.53 | $57,991.51 | -0.1% | +12.3% | +35.9% | |
| Mar 21, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 8,885 | $7.40 | $65,743.67 | -0.1% | +20.9% | +49.0% | |
| Mar 7, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 8,885 | $8.33 | $73,988.95 | -0.1% | +2.2% | +37.2% | |
| Feb 21, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 8,885 | $7.73 | $68,707.71 | -0.1% | +5.3% | +60.4% | |
| Feb 7, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 8,885 | $8.81 | $78,262.63 | -0.1% | -36.8% | +3.0% | |
| Jan 24, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 8,885 | $8.71 | $77,367.91 | -0.1% | -37.1% | +20.6% | |
| Jan 10, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Director | Sell | 8,885 | $7.69 | $68,283.00 | -0.1% | -16.3% | +60.3% |